VSMAX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
WHGAX
Price
$21.94
Change
+$0.06 (+0.27%)
Updated
Jul 31 closing price
Net Assets
874.81M
Interact to see
Advertisement

VSMAX vs WHGAX

VSMAX vs WHGAX Comparison Chart in %
View a ticker or compare two or three
VS
VSMAX vs. WHGAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VSMAX is a Hold and WHGAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMAX has more cash in the bank: 189B vs. WHGAX (875M). VSMAX pays higher dividends than WHGAX: VSMAX (1.21) vs WHGAX (0.54). VSMAX was incepted earlier than WHGAX: VSMAX (26 years) vs WHGAX (7 years). WHGAX (1.18) is less costly to investors than VSMAX (0.05). WHGAX is a more actively managed with annual turnover of: 63.00 vs. VSMAX (17.00). WHGAX has a lower initial minimum investment than VSMAX: WHGAX (1000) vs VSMAX (3000). VSMAX annual gain was more profitable for investors over the last year : 22.58 vs. WHGAX (9.26). VSMAX return over 5 years is better than : 35.11 vs. WHGAX (9.39).
VSMAXWHGAXVSMAX / WHGAX
Total Expense Ratio0.051.045%
Annual Report Gross Expense Ratio0.051.184%
Fund Existence26 years7 years-
Gain YTD14.58815.23196%
Front LoadN/A4%-
Min. Initial Investment30001000300%
Min. Initial Investment IRAN/AN/A-
Net Assets189B875M21,600%
Annual Yield % from dividends1.210.54223%
Returns for 1 year22.589.26244%
Returns for 3 years43.4211.87366%
Returns for 5 years35.119.39374%
Returns for 10 years155.96N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BQLCX23.420.17
+0.73%
Bright Rock Quality Large Cap Instl
GSPQX20.020.12
+0.60%
Goldman Sachs US Eq Div and Premium C
GSIYX24.29N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R6
CCWIX21.73-0.15
-0.69%
Baird Chautauqua International Gr Instl
RYOAX66.89-1.55
-2.26%
Rydex Biotechnology H